Evidence map›Paper›PMID 33165600›Full record

ArticleEuropean heart journal. Cardiovascular Imaging2021

EACVI survey on investigations and imaging modalities in chronic coronary syndromes.

Anda Bularga, Antti Saraste, Ricardo Fontes-Carvalho, Espen Holte, Matteo Cameli, Blazej Michalski, Michelle C Williams, Tomaz Podlesnikar, Antonello D'Andrea, Ivan Stankovic and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in European heart journal. Cardiovascular Imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 12 institutions in 10 countries.

Anda BulargaBHF Centre for Cardiovascular Science, Department of Cardiology, University of Edinburgh, Edinburgh, EH16 4SB, UK.
Antti SarasteEdinburgh, EH16 4SB, Heart Center, Turku University Hospital, Turku, 20520, Finland.
Ricardo Fontes-CarvalhoDepartment of Cardiology, Cardiovascular Research and Development Unit (UnIC), Faculty of Medicine, University of Porto, Porto, 4200-319, Portugal.
Espen HolteDepartment of Cardiology, St. Olavs Hospital, Trondheim, 7006, Norway.
Matteo CameliDepartment of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, 53100, Italy.
Blazej MichalskiDepartment of Cardiology, Medical University of Lodz, Lodz, 91-347, Poland.
Michelle C WilliamsBHF Centre for Cardiovascular Science, Department of Cardiology, University of Edinburgh, Edinburgh, EH16 4SB, UK.
Tomaz PodlesnikarDepartment of Cardiac Surgery, University Medical Centre Maribor, Maribor, 2000, Slovenia.
Antonello D'AndreaUnit of Cardiology, Department of Translational Medical Sciences, Monaldi Hospital, University of Campania 'Luigi Vanvitelli', Naples, 80121, Italy.
Ivan StankovicFaculty of Medicine, Department of Cardiology, Clinical Hospital Centre Zemun, University of Belgrade, Belgrade, 11080, Serbia.
Nicholas L MillsBHF Centre for Cardiovascular Science, Department of Cardiology, University of Edinburgh, Edinburgh, EH16 4SB, UK.
Robert MankaDepartment of Cardiology, University Heart Center, University Hospital Zurich, Zurich, 8091, Switzerland.
David E NewbyBHF Centre for Cardiovascular Science, Department of Cardiology, University of Edinburgh, Edinburgh, EH16 4SB, UK.
Jeanette Schultz-MengerDepartment of Cardiology and Nephrology, Charité Medical Faculty of the Humboldt University Berlin, Berlin, 13125, Germany.
Kristina H HaugaaDepartment of Cardiology, Oslo University Hospital, Oslo, 0424, Norway.
Marc R DweckBHF Centre for Cardiovascular Science, Department of Cardiology, University of Edinburgh, Edinburgh, EH16 4SB, UK.
University of Edinburgh · GBHumboldt-Universität zu Berlin · DEMedical University of Lodz · PLNorwegian University of Science and Technology · NOOslo University Hospital · NOTurku University Hospital · FIUniversidade do Porto · PTUniversity Clinical Centre Maribor · SIUniversity Hospital of Zurich · CHUniversity of Belgrade · RSUniversity of Campania "Luigi Vanvitelli" · ITUniversity of Siena · IT

Funding

British Heart Foundation CH/09/002British Heart Foundation CH/09/002/26360British Heart Foundation FS/14/78/31020British Heart Foundation FS/16/14/32023British Heart Foundation RE/18/5/34216Medical Research Council G0701127Medical Research Council MR/V007254/1Wellcome TrustWellcome Trust WT103782AIA
6 · The paper itself

Abstract

aimsThe European Association of Cardiovascular Imaging (EACVI) Scientific Initiatives Committee performed a global survey to evaluate current practice for the assessment and management of patients with suspected and confirmed chronic coronary syndromes. METHODS AND

resultsOne-hundred and ten imaging centres from 37 countries across the world responded to the survey. Most non-invasive investigations for coronary artery disease were widely available, except cardiovascular magnetic resonance (available 40% centres). Coronary computed tomography angiography (CCTA) and nuclear scans were reported by a multi-disciplinary team in only a quarter of centres. In the initial assessment of patients presenting with chest pain, only 32% of respondents indicated that they rely on pre-test probability for selecting the optimal imaging test while 31% proceed directly to CCTA. In patients with established coronary artery disease and recurrent chest pain, respondents opted for stress echocardiography (27%) and nuclear stress perfusion scans (26%). In asymptomatic patients with coronary artery disease and an obstructive (>70%) right coronary artery stenosis, 58% of respondents were happy to pursue medical therapy without further testing or intervention. This proportion fell to 29% with left anterior descending artery stenosis and 1% with left main stem obstruction. In asymptomatic patients with evidence of moderate-to-severe myocardial ischaemia (15%), only 18% of respondents would continue medical therapy without further investigation.

conclusionDespite guidelines recommendations pre-test probability is used to assess patients with suspected coronary artery in a minority of centres, one-third of centres moving directly to CCTA. Clinicians remain reticent to pursue a strategy of optimal medical therapy without further investigation or intervention in patients with controlled symptoms but obstructive coronary artery stenoses or myocardial ischaemia.

Indexed as

Coronary Artery DiseaseMyocardial Perfusion ImagingCoronary AngiographyHumansSurveys and QuestionnairesSyndromecoronary diseaseCTEACVIstress testingsurvey

Identifiers

PMID33165600
PMCPMC7758034
OpenAlexW3105350273

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.